Search
Plus Therapeutics Inc
PSTVAdd to Watchlist
4.160USD
-0.210-4.81%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
23.08MMarket Cap
LossP/E TTM
Plus Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-01The current valuation score of Plus Therapeutics Inc is 9.95, ranking 4 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.20, which is -93.60% below the recent high of -0.08 and -2100.77% above the recent low of -26.48.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.